📢 We will be attending the 42nd World Congress of Endourology and Urotechnology (WCET) in Phoenix. This global forum is the perfect setting to showcase the latest developments in minimally invasive urological surgery, and that's why we know that QP-Prostate, our artificial intelligence solution that optimizes fusion biopsy and focal therapy to improve precision in #ProstateCancer treatment, will be in its element. You will soon be able to meet our team—Edward Ramirez R.T. (R)(MR) B.S., David Bazaga, Nathan Clark, and Eric Draper— but for now, don't forget to book a demo: https://lnkd.in/dGsVHEhf #WCET2025 #Urology #AIinHealthcare #MedicalImaging #HealthcareInnovation
Delays in detection cost more than just time, leading to unnecessary treatments, advanced-stage diagnoses, and missed opportunities for better outcomes. With QP-Prostate, we are turning that once-imagined future into reality: precision meets efficiency so that all patients can benefit from timely and safe decisions. In the treatment of #ProstateCancer, time saved can mean lives saved. https://bit.ly/4lPQfl6 #HealthcareInnovation #EarlyDetection #PatientCare
Did you know about our blog section 𝐈𝐧 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡? These interviews offer a first-hand look at the ideas and people driving real change. Read from leading experts in medicine and technology as they delve into the challenges, trends, and advances shaping healthcare today. 📖 Don’t miss out—read all the fascinating conversations and get inspired! https://bit.ly/47CsQjm #HealthcareLeaders #HealthTech #MedTech #PatientCare
🗞️ In this article on the initiative to increase #ProstateCancer screening rates from 80% to 90%, The Telegraph highlights how the NHS England will adopt Quibim's technology to support early detection. Backed by a £2.6 million investment, the initiative will be rolled out across seven hospitals. Every year, more than 55,000 men in the UK are diagnosed with prostate cancer, but only half of cases are detected at an early stage, when treatment is most effective. QP-Prostate can help detect up to 11% more cases at this crucial time. To truly change outcomes, screening initiatives must become standard practice, something that organizations such as Prostate Cancer Research and leaders such as Rishi Sunak strongly advocate. 👉 https://lnkd.in/dR8KQnTB #AIinHealth #PrecisionMedicine #InnovationinHealth #HealthTech #Oncology
Professor Philippe PUECH is a leading figure in genitourinary imaging, leading international research and clinical guidelines in #ProstateCancer, among many other topics. From his work at the Department of Radiology in the CHU de Lille (France) and in the Inserm U1189 research lab, to releasing almost 200 publications, the organization of innovative teaching courses, or the development of high-impact medical software, Prof. Puech has consistently shaped how technology advances medicine and how informatics supports radiologists for prostate cancer imaging. Having voices like his on our advisory board reinforces our mission to transform medical images into actionable predictions. Welcome to Quibim, Professor Puech; your expertise will help us see further. #AI #radiology #medicalimaging #advisor #innovation #MRI
For urologists, PI-RADS 3 lesions remain one of the most complex issues in #ProstateCancer management: an equivocal lesion where the decision to perform a biopsy can be complex and often uncertain. That is why we are proud to share that the poster presented by Fundación Instituto Valenciano de Oncología (IVO) to the Spanish Association of Urology, “Artificial intelligence in PI-RADS 3 lesions: a potential tool for predicting clinically significant prostate cancer,” was awarded second prize for best communication at the national congress that took place in Cadiz last June 11-13. With Quibim’s collaboration, the study showed that QP-Prostate provides adequate sensitivity, specificity, and delivers a high negative predictive value — helping guide smarter biopsy decisions. Pedro De Pablos Rodríguez Paula Pelechano Gómez #Urology #MedicalInnovation #AIinHealthcare
🏅 We are proud to share that we have obtained the Great People Spain Mental Health certification! This recognition testifies that we are a company with an emotionally healthy, united, and committed team, ready to face new challenges together. Based on our employees' feedback in the latest Great Place to Work survey, this result is proof of the positive and supportive culture we are building every day. Today and always, we will continue to put people first, because a healthy team is the foundation of lasting impact. #MentalHealthAtWork #GreatPlaceToWork #TeamCulture
Who can benefit from the power of medical imaging beyond what the eye can see? Radiomics is transforming healthcare by extracting quantitative information from medical images, yielding data that improves diagnosis, prognosis and therapeutic decisions with a level of accuracy that traditional methods cannot achieve. The following organizations have decades of validated image data, and with QP-Insights, they can now extract unknown value from it, combining radiomics and clinical information for powerful, personalized insights. Explore the full infographic on our website 👉 https://bit.ly/4liZt9d #Radiomics #MedicalImaging #PersonalizedMedicine #AIInHealthcare #HealthTech
EXCITING NEWS: Quibim has been named as a supplier on Crown Commercial Service’s AI Dynamic Purchasing System (DPS) framework. This opportunity allows us to bring our AI-based healthcare technologies, including advanced diagnostic and medical imaging solutions, to the UK public sector, supporting government agencies, NHS organizations, charities, and others. This recognition highlights our commitment to turning data into insights — and insights into impact — as we work to transform healthcare and public services with the power of AI. #ArtificialIntelligence #HealthcareInnovation #MedicalImaging g#DPS #CrownCommercialService
July has been a month for reflecting on our growing commitment to the healthcare community and our ongoing innovation. From contributing to national initiatives to raising awareness about the importance of advancing research to address unmet needs, our goal remains to achieve real clinical impact. By collaborating with frontline professionals and learning from real-world cases, we continue to refine our AI solutions to enable more accurate diagnoses and safer, smarter decision-making in healthcare. Stay up to date through our monthly newsletter 👇 #AIinHealthcare #MedicalImaging #Innovation #PrecisionMedicine
